Bank Nifty index surged nearly 0.9 per cent, outpacing the benchmark indices, though marginally. The level of 25370 followed by 25150-25025 will act as major supports for the index.

Generics pharma giant Lupin announced the launch of Oseltamivir Phosphate Capsules in the US market. The drugmaker had earlier received USFDA approval for the same.

J Kumar Infraprojects' standalone revenue for the quarter came in at Rs. 457.16 crore, registering 23.9 per cent yoy increase.

The PAT for the quarter came in at Rs. 14.89 crore, yoy increase of 160.8 per cent. This was due to sharp jump in other income from Rs. 0.79 crore to Rs. 2.7 crore. Also, decline in interest expenses by 35 per cent yoy aided to bottomline growth.

The PAT for the quarter came in at Rs. 74.92 crore, yoy increase of 10 per cent. This was due to decline in effective tax rate from 5 to 3 per cent in Q3FY18.

The PAT for the quarter came in at Rs. 20.93 crore, yoy decline of 53.6 per cent. This was due to sharp decline in other income to Rs. 0.22 crore as against Rs. 5.03 crore in corresponding quarter of last year. 

Irrespective of what asset classes you favour more, your behavioural tendencies will always play a great role in your success or failure as an investor. It's strange but true that the behavioural traps do impact your investment decision and wealth creations. Here are some behavioural traps/biases which should be avoided by mutual fund investors in the upcoming year.

During the quarter, the company witnessed turnaround in net profit to Rs. 35.83 crore as against Rs. 0.37 crore net loss in the corresponding quarter of last year.

IndoStar Capital Finance, a non-banking finance company, has filed draft papers with Securities and Exchange Board of India to raise about Rs. 2,000 crore through an initial public offer (IPO).

The net loss for the quarter came in at Rs. 3.89 crore as compared to net profit of Rs. 3.08 crore in corresponding quarter last year. This includes tax adjustment of Rs. 1.90 crore for the earlier year.